Cargando…

The Antimalarial Chloroquine Reduces the Burden of Persistent Atrial Fibrillation

In clinical practice, reducing the burden of persistent atrial fibrillation by pharmacological means is challenging. We explored if blocking the background and the acetylcholine-activated inward rectifier potassium currents (I(K1) and I(KACh)) could be antiarrhythmic in persistent atrial fibrillatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tobón, Catalina, Palacio, Laura C., Chidipi, Bojjibabu, Slough, Diana P., Tran, Thanh, Tran, Nhi, Reiser, Michelle, Lin, Yu-Shan, Herweg, Bengt, Sayad, Dany, Saiz, Javier, Noujaim, Sami
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6890839/ https://www.ncbi.nlm.nih.gov/pubmed/31827438 http://dx.doi.org/10.3389/fphar.2019.01392

Ejemplares similares

All-Trans Retinoic Acid Increases DRP1 Levels and Promotes Mitochondrial Fission
por: Chidipi, Bojjibabu, et al.
Publicado: (2021)

I(KACh) is constitutively active via PKC epsilon in aging mediated atrial fibrillation
por: Chang, Mengmeng, et al.
Publicado: (2022)

Bioengineered peptibodies as blockers of ion channels
por: Chidipi, Bojjibabu, et al.
Publicado: (2022)

The Effects of Fibrotic Cell Type and Its Density on Atrial Fibrillation Dynamics: An In Silico Study
por: Palacio, Laura C., et al.
Publicado: (2021)

Major cardiac concerns in therapy and vaccinations for COVID-19
por: Junapudi, Syam Sundar, et al.
Publicado: (2021)

Antimalarials (chloroquine and hydroxychloroquine) in the COVID-19 pandemic()
por: Jáuregui, Edwin
Publicado: (2021)

Progress in the development of Reversed Chloroquine molecules as antimalarial therapy
por: Burgess, Steven J, et al.
Publicado: (2010)

Dual-functioning antimalarials that inhibit the chloroquine-resistance transporter
por: Egan, Timothy J, et al.
Publicado: (2013)

Persistence of chloroquine-resistant haplotypes of Plasmodium falciparum in children with uncomplicated Malaria in Lagos, Nigeria, four years after change of chloroquine as first-line antimalarial medicine
por: Oladipo, Oladosu O, et al.
Publicado: (2015)

Chloroquine analogs as antimalarial candidates with potent in vitro and in vivo activity
por: Aguiar, Anna C.C., et al.
Publicado: (2018)

A Review of Modifications of Quinoline Antimalarials: Mefloquine and (hydroxy)Chloroquine
por: Kucharski, Dawid J., et al.
Publicado: (2022)

Study of the antimalarial activity of 4-aminoquinoline compounds against chloroquine-sensitive and chloroquine-resistant parasite strains
por: Lawrenson, Alexandre S., et al.
Publicado: (2018)

Alterations of Mitochondrial Network by Cigarette Smoking and E-Cigarette Vaping
por: Kanithi, Manasa, et al.
Publicado: (2022)

Retinal toxicity to antimalarial drugs: chloroquine and hydroxychloroquine: a neurophysiologic study
por: Farrell, Donald F
Publicado: (2012)

Introducing New Antimalarial Analogues of Chloroquine and Amodiaquine: A Narrative Review
por: Parhizgar, Arezoo Rafiee, et al.
Publicado: (2017)

Building on Surface-Active Ionic Liquids for the Rescuing of the Antimalarial Drug Chloroquine
por: Silva, Ana Teresa, et al.
Publicado: (2020)

Gut Dysbiosis and Immune System in Atherosclerotic Cardiovascular Disease (ACVD)
por: Yoo, Ji Youn, et al.
Publicado: (2022)

Antimalarial chloroquine metamorphosed into antiviral agent against HIV with four modes of actions
por: Chandramohan, M, et al.
Publicado: (2012)

Influence of LAR and VAR on Para-Aminopyridine Antimalarials Targetting Haematin in Chloroquine-Resistance
por: Warhurst, David C., et al.
Publicado: (2016)

Antimalarial Activity of Kaempferol and Its Combination with Chloroquine in Plasmodium berghei Infection in Mice
por: Somsak, Voravuth, et al.
Publicado: (2018)

Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine
por: Tsuji, Gaku, et al.
Publicado: (2021)

Coupling the Antimalarial Cell Penetrating Peptide TP10 to Classical Antimalarial Drugs Primaquine and Chloroquine Produces Strongly Hemolytic Conjugates
por: Aguiar, Luísa, et al.
Publicado: (2019)

Correction: Influence of LAR and VAR on Para-Aminopyridine Antimalarials Targetting Haematin in Chloroquine-Resistance
por: Warhurst, David C., et al.
Publicado: (2016)

Identification of antimalarial targets of chloroquine by a combined deconvolution strategy of ABPP and MS-CETSA
por: Gao, Peng, et al.
Publicado: (2022)

Antimalarial Activity and Mechanisms of Action of Two Novel 4-Aminoquinolines against Chloroquine-Resistant Parasites
por: Aguiar, Anna Caroline Campos, et al.
Publicado: (2012)

Antimalarial drug chloroquine counteracts activation of indoleamine (2,3)-dioxygenase activity in human PBMC
por: Gostner, Johanna M., et al.
Publicado: (2012)

Randomized Dose-Ranging Controlled Trial of AQ-13, a Candidate Antimalarial, and Chloroquine in Healthy Volunteers
por: Mzayek, Fawaz, et al.
Publicado: (2007)

Monitoring the Response of Plasmodium vivax to Chloroquine and Uncomplicated P. falciparum to Artesunate-fansidar Antimalarials in Southeastern Iran
por: AZARIAN MOGHADAM, Hamid, et al.
Publicado: (2018)

Air Pollution and Cardiac Diseases: A Review of Experimental Studies
por: Palacio, Laura C., et al.
Publicado: (2023)

Confirmed Plasmodium vivax Resistance to Chloroquine in Central Vietnam
por: Thanh, Pham Vinh, et al.
Publicado: (2015)

Chloroquine Interference with Hemoglobin Endocytic Trafficking Suppresses Adaptive Heme and Iron Homeostasis in Macrophages: The Paradox of an Antimalarial Agent
por: Schaer, Christian A., et al.
Publicado: (2013)

Copper (I)-Chloroquine Complexes: Interactions with DNA and Ferriprotoporphyrin, Inhibition of β-Hematin Formation and Relation to Antimalarial Activity
por: Villarreal, Wilmer, et al.
Publicado: (2022)

A multi centre randomized open label trial of chloroquine for the treatment of adults with SARS-CoV-2 infection in Vietnam
por: Kestelyn, Evelyne, et al.
Publicado: (2020)

Decreased availability of antimalarials in the private sector following the policy change from chloroquine to sulphadoxine-pyrimethamine in the Kilombero Valley, Tanzania
por: Hetzel, Manuel W, et al.
Publicado: (2006)

The Antimalarial Chloroquine Suppresses LPS-Induced NLRP3 Inflammasome Activation and Confers Protection against Murine Endotoxic Shock
por: Chen, Xiaoli, et al.
Publicado: (2017)

Chloroquine: Autophagy inhibitor, antimalarial, bitter taste receptor agonist in fight against COVID-19, a reality check?
por: Sharma, Pawan, et al.
Publicado: (2021)

The effect of chloroquine dose and primaquine on Plasmodium vivax recurrence: a WorldWide Antimalarial Resistance Network systematic review and individual patient pooled meta-analysis
por: Commons, Robert J, et al.
Publicado: (2018)

Research influence on antimalarial drug policy change in Tanzania: case study of replacing chloroquine with sulfadoxine-pyrimethamine as the first-line drug
por: Mubyazi, Godfrey M, et al.
Publicado: (2005)

Hemozoin‐induced activation of human monocytes toward M2‐like phenotype is partially reversed by antimalarial drugs—chloroquine and artemisinin
por: Bobade, Deepali, et al.
Publicado: (2018)

Fluorescence spectra of chloroquine suspension: A probable tool for quality assessment of the most common antimalarial in a user-friendly manner
por: Kaur, Sumanpreet, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t968neeg740l4nnlfkeh7l9vn2